111 assistant-professor-and-data-visualization Postdoctoral positions at Stanford University
Sort by
Refine Your Search
-
Posted on Tue, 02/25/2025 - 17:04 Important Info Deprecated / Faculty Sponsor (Last, First Name): Alsentzer, Emily Stanford Departments and Centers: Biomedical Data Sciences Postdoc Appointment Term
-
expertise in Neuropixels or other large-scale in vivo electrophysiology techniques. An expert neural data analyst may be considered even with minimal animal experience. Required Application Materials: Cover
-
understanding of neuroscience but also advanced technical expertise in machine learning, artificial intelligence, and data modeling approaches. Responsibilities: Conduct research on the mechanisms underlying
-
, leveraging a variety of designer (e.g. SpCas9, SaCas9, Cas12, etc.) and physiological (e.g. RAG1/2, AID, SPO11, etc.) endonucleases to elucidate DSB repair and off-targeting mechanisms in their surrounding
-
. For more information visit our lab website baronelab.org (link is external) . Interested applicants should send their CV and a cover letter to Vanessa (link sends e-mail) . Preferred start date September
-
blockade (Phillips, Matusiak, et al, Nature Communications, 2021). We do research at the forefront of spatial biology and offer training in immunology, human histology, statistics, computer vision, grant
-
well as the military realm (battlefield trauma, long term space flight, antidotes to chemical weapons, etc.). If interested please feel free to contact Professor Ed Bertaccini at edwardb@stanford.edu (link sends e-mail
-
per year related to East Asian archaeology and assist with other courses as needed. Engage with faculty and graduate students at the Center. Contribute to the organization of an international workshop
-
Application Materials: Please send your application package as a zipped file to kseetah@stanford.edu (link sends e-mail) , with the subject line: Application for 'Integrating Natural and Cultural Data' postdoc
-
research on multimodal data from patients receiving engineered T cell immunotherapies. We have recently completed groundbreaking clinical studies of CD19/CD22-targeted and GD2-targeted CAR T cell therapies